27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Following the market opening Tuesday, the Dow traded up 0.5% to 28677.15 while the NASDAQ rose 0.86% to 9217.79. The S&P also rose, gaining 0.77% to 3,268.55.
Leading and Lagging Sectors
Information technology shares climbed 1% on Tuesday. Meanwhile, top gainers in the sector included Servicesource International Inc (NASDAQ:SREV), up 8%, and Sprout Social Inc (NASDAQ:SPT), up 5%.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
In trading on Tuesday, industrial shares rose by just 0.2%.
Top Headline
Pfizer Inc. (NYSE:PFE) reported weaker-than-expected results for its fourth quarter.
Pfizer reported quarterly earnings of $0.55 per share, which missed the analyst consensus estimate of 57 cents. The company reported quarterly sales of $12.7 billion, which beat the analyst consensus estimate of $12.61 billion.
Pfizer sees fiscal year 2020 adjusted EPS $2.82-$2.92 versus the $2.90 estimate and sales $48.5 billion-$50.5 billion versus the $49.52 billion estimate.
Equities Trading UP
Armata Pharmaceuticals, Inc. (NYSE:ARMP) shares shot up 109% to $5.83. Armata Pharmaceuticals and Innoviva reported a $25 million strategic investment to support advancement of Armata's bacteriophage development programs.
Shares of Delphi Technologies PLC (NYSE:DLPH) got a boost, shooting up 63% to $15.92 after the company announced it will be acquired by BorgWarner for $3.3 billion in an all-stock transaction.
Acceleron Pharma Inc. (NASDAQ:XLRN) shares were also up, gaining 52% to $80.20 following a data readout. Acceleron said a Phase 2 study dubbed PULSAR that evaluated its sotatercept in patients with pulmonary arterial hypertension, or PAH, met its primary and key secondary endpoints. The experimental drug showed a statistically significant reduction in pulmonary vascular resistance – the primary endpoint - at week 24 versus placebo. The study also achieved the key secondary endpoint of significant improvements in six-minute walk distance, and other secondary endpoints, including amino-terminal brain natriuretic propeptide, and WHO functional class. It was also found to be generally well tolerated.
FREE REPORT: How To Learn Options Trading Fast
In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.
Equities Trading DOWN
NanoViricides, Inc. (NYSE:NNVC) shares tumbled 31% to $10.87 after surging 86.98% on Monday.
Shares of TESSCO Technologies Incorporated (NASDAQ:TESS) were down 25% to $9.07 after the company reported downbeat Q3 results.
Allied Healthcare Products, Inc. (NASDAQ:AHPI) was down, falling 23% to $3.3547 after surging 50% on Monday.
Commodities
In commodity news, oil traded down 0.1% to $53.07, while gold traded down 0.1% to $1,577.20.
Silver traded down 0.4% Tuesday to $17.985, while copper fell 0.3% to $2.5885.
Euro zone
European shares were mostly higher today. The eurozone’s STOXX 600 gained 0.1%, the Spanish Ibex Index rose 0.5%, while Italy’s FTSE MIB Index rose 1.1% Meanwhile, the German DAX dropped 0.1%, and the French CAC 40 rose 0.2% while UK shares rose 0.3%.
Economics
The Federal Open Market Committee will begin its two-day policy meeting today.
U.S. durable goods orders rose 2.4% in December, versus a revised 3.1% decline in the previous month.
The Johnson Redbook Retail Sales Index rose 0.1% during the first three weeks of January versus December.
The S&P Corelogic Case-Shiller home price index climbed 2.6% year-over-year in November, compared to a 2.2% rise in the previous month.
The Treasury is set to auction 52-week bills at 11:30 a.m. ET.
The Treasury will auction 7-year notes at 1:00 p.m. ET.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.